H
Harvest
Tax-loss replacement research
RGEN
Repligen
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for RGEN

Among the 28 Biotechnology peers screened, FTRE (Fortrea) has tracked RGEN most closely over the past year, with a return correlation of 0.47. The strongest fund stand-in is ARKG (ARK Genomic Revolution ETF) at 0.55 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
FTREFortreaBiotechnology0.470.360.34
VCELVericelBiotechnology0.360.310.370.31
INCYIncyteBiotechnology0.290.220.250.29
AMGNAmgen Inc.Biotechnology0.250.230.190.27
BMRNBioMarin PharmaceuticalBiotechnology0.250.280.310.33
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.240.280.300.32
ADMAADMA Biologics, Inc.Biotechnology0.240.240.260.19
KRYSKrystal BiotechBiotechnology0.230.230.210.23
MRNAModerna Inc.Biotechnology0.230.220.270.23
SRPTSarepta TherapeuticsBiotechnology0.200.180.200.21
VRTXVertex PharmaceuticalsBiotechnology0.200.210.220.30
HALOHalozymeBiotechnology0.200.230.270.32
EXELExelixisBiotechnology0.200.160.210.26
ROIVRoivant SciencesBiotechnology0.190.250.23
REGNRegeneron PharmaceuticalsBiotechnology0.180.250.270.30
NBIXNeurocrine BiosciencesBiotechnology0.180.230.240.29
BIIBBiogen Inc.Biotechnology0.180.260.250.23
ARWRArrowhead PharmaceuticalsBiotechnology0.170.320.360.30
XNCRXencor IncBiotechnology0.170.270.290.32
ALNYAlnylam PharmaceuticalsBiotechnology0.170.160.210.26
GILDGilead SciencesBiotechnology0.160.150.160.22
CYTKCytokineticsBiotechnology0.150.180.230.24
VIRVir Biotechnology, Inc.Biotechnology0.150.260.290.19
TGTXTG Therapeutics, Inc.Biotechnology0.150.190.270.27
RCUSArcus Biosciences, Inc.Biotechnology0.140.230.270.27
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.110.200.24
PTGXProtagonist Therapeutics, Inc.Biotechnology0.070.060.120.12
UTHRUnited TherapeuticsBiotechnology0.040.110.120.20
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.550.530.560.56
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.450.460.510.51
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.450.510.570.56
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.450.460.510.51
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.430.440.490.49
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.410.420.460.46
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.380.420.510.51
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.360.440.490.52
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.350.430.480.48
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.330.310.350.40
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.320.340.380.44
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.170.230.300.34
NEXT STEPS

Harvesting a loss in RGEN?

RELATED

Replacement research for RGEN's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.